immunotherapy

American  

[im-yuh-noh-ther-uh-pee, ih-myoo-] / ˌɪm jə noʊˈθɛr ə pi, ɪˌmju- /

noun

• immunotherapies
  plural

1. treatment designed to produce immunity to a disease or enhance the resistance of the immune system to an active disease process, as cancer.

---

immunotherapy British  

/ ˌɪmjʊnəʊˈθɛrəpɪ /

noun

1. med the treatment of disease by stimulating the body's production of antibodies

---

Other Word Forms

Derived Forms

• immunotherapeutic
  adjective

Inflected Forms

Nouns

• immunotherapies
  plural

---

Etymology

Origin of immunotherapy

First recorded in 1905–10; immuno- + therapy

---

Example Sentences

See Examples For:

immunotherapy immunotherapies

Beyaz believes the discoveries represent only the "tip of the iceberg" when it comes to finding new ways to strengthen cancer immunotherapy.

From Science Daily ● Oct. 16, 2026

CAR technology is already an important part of cancer immunotherapy, particularly in treatments that modify a patient's T cells to recognize and attack cancer.

From Science Daily ● Oct. 16, 2026

He received three doses of immunotherapy across nine weeks before undergoing surgery in May 2023.

From Science Daily ● Oct. 10, 2026

If approved by the voters, the measure will provide $8.4 billion in funding for immunology and immunotherapy research that aims to cure and prevent cancer, heart disease and Alzheimer’s disease.

From Los Angeles Times ● Oct. 1, 2026

“As a daughter of a lung cancer survivor who had one year of immunotherapy, and as a registered nurse, I have seen firsthand the value of immunotherapy,” Tarver said in a statement.

From Los Angeles Times ● Oct. 1, 2026

Roughly half of advanced melanoma patients’ diseases eventually progress while taking immunotherapies like Opdivo and Merck’s Keytruda.

From The Wall Street Journal ● Aug. 6, 2026

Many patients with metastatic melanoma don’t respond to, or develop resistance to, other front-line immunotherapies.

From The Wall Street Journal ● Jul. 31, 2026

This shift could significantly improve the effectiveness of existing immunotherapies.

From Science Daily ● Jul. 9, 2026

Many of today's cancer immunotherapies are designed to activate killer T cells, but only about 20% to 40% of patients experience meaningful benefits.

From Science Daily ● Jul. 8, 2026

More than half of patients with metastatic melanoma will stop responding to approved immunotherapies, after which most won’t live much more than a year.

From The Wall Street Journal ● May 29, 2026

Random Word

Spin the wheel and learn a new word!

---